Investing.com -- Stryker Corporation (NYSE:SYK) reported better-than-expected fourth quarter results on Thursday, sending shares up 4% in after-hours trading as the medical technology company delivered double-digit growth in both sales and adjusted earnings. The medical device maker reported fourth quarter adjusted earnings per share of $4.47, exceeding analyst estimates of $4.39. Organic sales growth was robust at 11.0%, driven primarily by a 10.9% increase in unit volume. For the full year 2025, Stryker reported an 11.2% increase in sales to $25.1 billion, with organic growth of 10.3%. Related articlesStryker shares higher as fourth quarter results beat expectationsGoldman expects lower but still attractive stock market returns in 2026Morgan Stanley CIO survey: Why AI hype isn’t boosting 2026 IT budgets